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Abstract
We conducted a survey to examine whether reimbursement levels are associated with the quality
of adolescent substance use treatment programs in the United States. Between March and
September 2005, telephone and written surveys were administered to program, clinical, and
finance directors of previously surveyed highly regarded programs. Differences in quality scores
were compared for programs with above versus below median reimbursement levels and examined
in multivariate regression models constructed separately for programs offering residential and
outpatient treatment. In residential treatment multivariate regression models, higher quality scores
were associated with higher reimbursement, but this relationship was not observed for outpatient
treatment. Even the highest level of outpatient reimbursement received may be too low to support
quality improvement initiatives. Our results suggest that higher reimbursement may be a necessary
component of quality improvement for residential adolescent drug treatment programs, and
emphasize the need for further research to determine what levels of reimbursement and insurance
coverage policies will encourage the expansion of high quality outpatient programs.
Background
Although substance abuse is pervasive among American
youth, only one in ten adolescents who need treatment
actually receives help [1]. Adolescents differ from adults
in terms of patterns of substance use, the influence of
developmental and social factors, and the prevalence of
co-occurring disorders [2]. Treatment experts agree that
adolescent programs should not simply be adult pro-
grams modified for adolescents. Adolescent treatment
programs must address the different contexts that shape
an adolescent's life including school, recreation, peers, the
distinctive nature of the juvenile justice system, and differ-
ences in medical care [3].
Costs are a major concern for parents and professionals
who refer adolescents to treatment, particularly for resi-
dential programs. Charges for outpatient programs are
generally lower, because most adolescents attend just two
to five outpatient sessions per week, but they can still
impost a financial burden. Private insurance spending for
drug and alcohol abuse treatment has declined, while
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cost-sharing requirements have increased for those with
insurance [4].
Substance abuse treatment providers report that lower
reimbursement and greater administrative burdens are
associated with difficulties attracting and retaining better-
trained staff, and coping with overworked staff [5]. One
would expect that higher reimbursement would also be
associated with more treatment, more therapeutic hours
or more frequent treatment contacts, which have been
found to be associated with improved outcomes (e.g.
fewer positive urinalysis results, fewer readmissions)
[6,7]. Studies have evaluated the impact on substance
abuse outcomes of reimbursement systems such as Med-
icaid managed care [8,9] and performance-based contract-
ing [10,11], but we found no empirical studies that
directly evaluate associations between reimbursement
rates and substance abuse treatment program quality.
However, high-quality pediatric and adolescent preven-
tive care has been found to be associated with higher
reimbursement [12], and higher quality child day care
centers also have higher costs [13].
In a previous study, we evaluated the quality of 144 ado-
lescent treatment programs identified as exemplary by
professionals in the field, directors of state drug and alco-
hol agencies, and major national organizations [14]. To
examine whether there is any direct association between
the cost and quality of these programs, we collected new
information on reimbursement levels in a follow-up sur-
vey.
Methods
Sample
In the previous study, alcohol and drug abuse agencies in
all 50 states, several national organizations and federal
agencies (including the American Medical Association,
the American Academy of Pediatrics, and the National
Institute of Drug Abuse), and members of an expert panel
were requested to identify adolescent substance use treat-
ment programs that they considered to be exemplary and
thus highly regarded [14].
The sample for this study consists of 138 programs still in
operation of the 144 programs that had been selected to
participate in the previous study. Three surveys were con-
ducted between March 2005 and September 2005: an in-
depth telephone survey administered to program direc-
tors, and two telephone or written surveys administered
to clinical and finance directors.
Measures
Respondents to the finance director survey were asked to
indicate the average reimbursement per day, per week or
per stay by treatment setting and the proportion of reim-
bursements by type of payer (government, private insurer,
self-pay). If residential reimbursement levels were
reported in monthly or weekly units, these responses were
divided by their respective time frame to have a uniform
time unit for reimbursements. If reimbursement levels
were reported per stay, these responses were divided by
the average length of stay reported by the program.
In the previous study, a panel of 22 experts defined 9 key
elements of effective treatment for adolescent substance
abuse based on a review of the literature, interviews and
discussions with panel members, and small working
group recommendations. Open-ended survey responses
were then coded according to 45 quality components
based on these 9 key elements with a reliability of 0.79 as
measured by Cronbach's α with standardized items [14].
In this study, the 45 quality components were condensed
to a 20-item quality score according to the following pro-
cedure. First, patterns of missing data and the extent of
variation in the responses were used to reduce the number
of questions from 45 to 31. Then, a factor analysis was
conducted on the remaining questions using a cut-off of
0.4 on factor loading [15]. The 20 questions with the
highest factor loading explained 85% of the variation in
the previous study survey responses. These 20 questions
comprised the quality score for this study (see Appendix).
Additional variables that were repeated from the previous
study included treatment approaches used (twelve-step,
cognitive behavioral, therapeutic community, motiva-
tional enhancement, multi-systemic therapy, and multidi-
mensional family therapy), geographical region, and
accreditation. We also obtained data on other variables
potentially associated with reimbursement level, includ-
ing the presence of a waiting list to enter the program,
referral sources, average daily client census, program treat-
ment slots and average length of stay (inpatient) or treat-
ment duration (outpatient). An occupancy ratio was
calculated for each program that provided an average
daily client census and program treatment slots.
Analysis
Since reimbursement for residential services differs signif-
icantly from reimbursement for outpatient services, we
conducted separate analyses for each of these services. The
sample size was insufficient to develop three separate
models for programs offering residential only, outpatient
only, and both services. Differences in median quality
scores were analyzed by reimbursement level and other
program characteristics using the Mann-Whitney test, and
we report approximate z-scores using this test. Because we
consider this analysis to be exploratory in nature given the
lack of relevant previous research conducted on this topic,
all variables with p-values ≤ 0.25 were entered into linear
regression models and final multivariate linear regressionSubstance Abuse Treatment, Prevention, and Policy 2007, 2:23 http://www.substanceabusepolicy.com/content/2/1/23
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models were constructed using the backward elimination
procedure [16]. An advantage of using this procedure over
forward selection and stepwise regression is that the pre-
dictive capability of all variables of potential interest can
be examined jointly [17].
Results
Response rates were 87% for program directors, 60% for
clinical directors, and 57% for financial directors. Table 1
provides an overview of program characteristics for all
programs (n = 120) and for programs with sufficient data
from all interviews to be included in regression models (n
= 63). There are no notable differences between programs
included versus excluded from the regression models, and
approximately 40% of residential-only programs, 50% of
outpatient-only programs, and 50% of programs provid-
ing both residential and outpatient services were included
in the regression models. The mean daily reimbursement
reported for residential services was $201 compared to
$56 for outpatient services (Table 2). The mean quality
score for all programs was 14.28 out of a possible 20 and
for programs included in the regression models the mean
quality was 14.77, with no significant differences by set-
ting.
Among programs offering residential services, factors
individually associated with a higher quality score in
bivariate analyses included higher average daily reim-
bursement (Mann-Whitney z = 2.12, p = 0.04), multisys-
temic therapy (Mann-Whitney z = 2.12, p = 0.03),
Table 1: Program characteristics
All Programs Programs in Reduced Regression Models
Offering Residential Treatment Offering Outpatient Treatment
N% N % N %
Program Setting
Residential only 27 22.5 10 26.3 -
Outpatient only 42 35.0 - 20 37.7
Multilevel 51 42.5 28 73.7 33 62.3
Program Approach*
Twelve-step 94 80.3 32 84.2 40 75.5
Cognitive behavioral 105 89.7 36 94.7 47 88.7
Therapeutic Community 45 38.5 15 39.5 16 30.2
Motivational Enhancement 82 70.1 27 71.0 40 75.5
Multisystematic therapy 51 43.6 19 50.0 23 43.4
Multidimensional Family 61 52.1 18 47.4 23 43.4
Region
South 36 30.0 7 18.4 12 22.6
Midwest 28 23.3 9 23.7 15 28.3
West 30 25.0 12 31.6 16 30.2
Northeast 26 21.7 10 26.3 10 18.9
Source of Referral*
Hospital 46 38 17 44.7 23 43.4
Juvenile Justice System 107 89 32 84.2 49 92.4
Private Practitioner 58 48 19 50.0 28 52.8
State health agency 47 39 16 42.1 20 37.7
Adult Substance Abuse 17 14 6 15.8 9 17.0
Facility
School System Official 83 69 22 57.9 42 79.3
Parent or Family Member 98 82 30 78.9 46 86.8
Insurance Company 34 28 13 34.2 17 32.1
Walk-ins 47 39 14 36.8 20 37.7
Programs w/accreditation†
Yes 63 54.3 22 57.9 30 56.6
No 53 45.7 16 42.1 23 43.4
Total Revenue >$1 million 42 56.0 29 76.3 28 53.8
Total Revenue <$1 million 33 44.0 9 23.7 24 46.2
Receive Grants
Yes 52 75.4 25 69.4 43 81.1
No 17 24.6 11 30.6 10 18.9
Waiting List
Yes 37 50.7 26 70.3 26 49.1
No 36 49.3 11 29.7 27 50.9
Note: excludes missing responses.
* Multiple responses allowed
† Joint Commission on Accreditation of Healthcare Organizations (JCAHO), Rehabilitation Accreditation Commission (CARF), Council on Accreditation (COA)Substance Abuse Treatment, Prevention, and Policy 2007, 2:23 http://www.substanceabusepolicy.com/content/2/1/23
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motivational enhancement therapy (Mann-Whitney z = (-
)2.05, p = 0.04), and accepting client referrals from hospi-
tals (Mann-Whitney z = 2.22, p = 0.03), private practition-
ers (Mann-Whitney z = (-)2.92, p < 0.01), or insurance
companies (Mann-Whitney z = 2.15, p = 0.03). However,
the only significant predictor of a higher quality score in
the final multivariate model for these programs was
higher residential reimbursement (t = 2.24, df = 35, p =
0.03) (Table 3).
Among programs offering outpatient services, factors
individually associated with a higher quality score in
bivariate analyses included monthly staff training (Mann-
Whitney z = 2.16, p = 0.03), having a waiting list (Mann-
Whitney z = 2.22, p = 0.03), multisystemic therapy
(Mann-Whitney z = 2.59, p = 0.01), and accepting client
referrals from hospitals (Mann-Whitney z = 2.25, p =
0.02) and private practitioners (Mann-Whitney z = (-
)2.43, p = 0.02). In the final multivariate model for these
programs, a higher quality score was associated with hav-
ing a waiting list to enter the program (t = 2.45, df = 48, p
= 0.02), having received accreditation from a national
organization (t = 3.07, df = 48, p < 0.01) and having
received grants (t = 2.32, df = 48, p = 0.02); there was no
significant association with reimbursement level (Table
4).
Discussion
We conducted surveys of program, clinical, and finance
directors of highly regarded adolescent substance use
treatment programs to examine whether reimbursement
levels are associated with program quality. Our analysis
was subject to several limitations. Our surveys were lim-
ited to highly regarded programs and there was a relatively
narrow range of variation in quality. Hence the effect size
of reimbursement on quality was relatively small: an addi-
tional 1.0 quality point was associated with residential
reimbursement above the median compared to a mean
(standard deviation) quality score of 14.6 (1.6). With
more complete data from programs with greater varia-
tions in quality and size, we could have seen a greater
reimbursement effect.
Our cross-sectional design is vulnerable to reverse causal-
ity, in this instance the possibility that higher quality pro-
grams are able to obtain greater reimbursement due to
Table 3: Multivariate regression models predicting quality score among programs offering residential treatment
A. Full Model B. Reduced Model (backward elimination procedure)
R-square = 0.249, n = 38 R-square = 0.185, n = 38
Variable β p-value Variable β p-value
Residential Reimbursement Above Median 1.01 0.03 Residential Reimbursement Above Median 1.01 0.03
Residential Census Above Median 0.67 0.15 Residential Census Above Median 0.67 0.15
Motivational Enhancement Therapy 0.28 0.61
Multisystemic Therapy -0.03 0.96
Receive Hospital Referrals 0.46 0.47
Receive Private Practitioner Referrals 0.03 0.96
Receive Insurance Company Referrals 0.41 0.49
With Accreditation* 0.20 0.70
* Joint Commission on Accreditation of Healthcare Organizations (JCAHO), Rehabilitation Accreditation Commission (CARF), Council on 
Accreditation (COA)
Table 2: Client utilization, reimbursement and quality score for residential and outpatient services
Variable N Median Mean SD
Programs offering residential treatment*
Average daily client census 49 26.0 43.4 59.0
Client occupancy ratio (%)† 49 87.7 86.2 0.1
Average length of stay (days) 47 96.0 118.8 92.8
Daily residential reimbursement ($) 38 183.00 200.92 99.72
Quality Score# 78 15.0 14.6 1.6
Programs offering outpatient treatment*
Average daily client census 59 20.0 39.7 57.1
Client occupancy ratio (%)† 47 50.0 55.9 0.3
Average treatment duration (days) 47 120.0 131.7 92.8
Daily outpatient reimbursement ($) 26 50.50 55.73 26.47
Quality Score# 93 15.0 14.3 1.9
* residential treatment = residential only or both residential and outpatient; outpatient treatment = outpatient only or both residential and outpatient
† occupancy ratio = number of clients/number of available client slots
# Maximum score is 20Substance Abuse Treatment, Prevention, and Policy 2007, 2:23 http://www.substanceabusepolicy.com/content/2/1/23
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consumer demand as opposed to higher reimbursement
directly supporting better quality. However, most adoles-
cent substance use treatment programs are non-profits
and there is little evidence of high profit margins in this
setting.
Our analysis indicates that higher cost residential adoles-
cent programs deliver better quality treatment, suggesting
that higher reimbursement may be a necessary compo-
nent of quality improvement for these types of programs.
However, we found no association between higher cost
for outpatient programs and better quality treatment.
High quality outpatient treatment appears to be recog-
nized externally when it occurs, since better quality was
associated with waiting lists, accreditation, and success in
obtaining external funding. However, we believe that even
the highest level of outpatient reimbursement received
(e.g. $84 per day for the top quartile of outpatient reim-
bursement) is still too low to have an effect on quality.
The great majority of adolescents receive treatment in out-
patient settings rather than in residential settings [18].
Further research is needed to determine what levels of
reimbursement and insurance coverage policies will
encourage the expansion of high quality outpatient pro-
grams.
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Appendix: 20-item Program Quality Score 
Questions
1. Does the program either provide mental health services
for clients onsite or coordinate their care with community
mental health providers?
2. Do you conduct some form of reassessment of clients
during the course of treatment?
3. In screening and assessment process, does the program
use either a standardized instrument* or a structured clin-
ical interview?
4. In your screening and assessment process, does the pro-
gram use a standardized mental health instrument*?
5. Does the treatment plan address mental health issues?
6. Do you provide the client's family with individual and/
or multifamily therapy sessions?
7. Will you refer parents who are abusing substance to
treatment?
8. Do you maintain contact with juvenile justice officials
regarding clients who have been referred by the juvenile
justice system?
9. Do you utilize a specific text or curriculum designed for
adolescents?
10. Are adolescent clients typically treated only with other
adolescents, as opposed to being integrated with adult cli-
ents?
Table 4: Multivariate regression models predicting quality score among programs offering outpatient treatment
A. Full Model B. Reduced Model (backward elimination procedure)
R-square = 0.462, n = 23 R-square = 0.261, n = 53
Variable β p-value Variable β p-value
Outpatient Reimbursement Above Median 0.36 0.69 Waiting List 0.99 0.02
Waiting List 1.35 0.14 With Accreditation* 1.31 <0.01
With Accreditation* 1.62 0.14 Receive Grants 1.36 0.02
Receive Grants 1.20 0.37 Receive Insurance Company Referrals 0.85 0.08
Receive Insurance Company Referrals 1.48 0.21
Motivational Enhancement Therapy -0.49 0.68
Multisystemic Therapy 0.74 0.31
Receive Hospital Referrals 0.47 0.60
*Joint Commission on Accreditation of Healthcare Organizations (JCAHO), Rehabilitation Accreditation Commission (CARF), Council on 
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11. Do you incorporate positive reinforcements, such as
increasing responsibilities and/or privileges?
12. Do you utilize special recreational programming or
offer courses of particular interest to adolescents?
13. Do you provide clients with gender-specific group ses-
sions?
14. Does your program tailor itself for gay and lesbian
youth?
15. Do you create a continuing care plan for the client
beyond referring clients to outside services?
16. Does the program link clients with relevant commu-
nity services upon discharge?
17. Do you collect any other information related to client
outcomes after treatment?
18. Are there any evaluation or other types of studies com-
pleted on your program, and if so, may we receive a copy?
19. Do you have staff members with training in mental
health issues?
20. Do all clinical supervisors possess at least a master's
degree?
* Standardized instruments sources: [19,20]
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